首页 | 本学科首页   官方微博 | 高级检索  
     

瑞舒伐他汀对高龄不稳定心绞痛患者血脂及高敏C反应蛋白的影响
引用本文:杨绍祥,左芳,李彬. 瑞舒伐他汀对高龄不稳定心绞痛患者血脂及高敏C反应蛋白的影响[J]. 中国实用医药, 2012, 7(24): 61-62
作者姓名:杨绍祥  左芳  李彬
作者单位:济南市中心医院保健病房,250013
摘    要:目的 探讨瑞舒伐他汀对高龄不稳定心绞痛(UA)患者血脂及高敏C反应蛋白(hs-CRP)的影响及安全性.方法 选择80例高龄不稳定心绞痛患者,随机分为治疗组和对照组(常规治疗基础上加用瑞舒伐他汀10 mg,qd),于治疗前、治疗后4周、12周检测血脂、hs-CRP及肝肾功能.然后进行对比分析.结果 治疗后4周TC、LDL-C、hs-CRP较对照组及治疗前均显著降低(P<0.01),12周时仍进一步降低.结论 瑞舒伐他汀显著改善高龄UA患者血脂及hs-CRP,且应用安全.

关 键 词:瑞舒伐他汀  高龄  不稳定心绞痛  血脂  C反应蛋白

The Effects of Rosuvastatin on blood lipid and High Sensitive C-reaction in unstable angina patiens
YANG Shao-xiang , ZUO Fang , LI Bin. The Effects of Rosuvastatin on blood lipid and High Sensitive C-reaction in unstable angina patiens[J]. China Practical Medical, 2012, 7(24): 61-62
Authors:YANG Shao-xiang    ZUO Fang    LI Bin
Affiliation:.Medical Care Department for personnel,Jinan Central Hospital,Jinan 250031,China
Abstract:Objective To evaluate the effects and safety of rosuvastatin on blood lipid and high sensitive C-reaction protein(hs-CRP)in unstable angina(UA) patiens.Methods Eighty Aged patiens with UA were random1y assigned to rosuvastatin treatment(rosuvastatin 10 mg/d) group and control group.The blood lipid(TC,LDL-C,HDL-C,TG),hs-CRP,ALT,Cr and CK from those two groups were detected before treatmen and at the fourth week and twelfth week of treatmen.Results The TG,TC,LDL-C and hs-CRP of the rosuvastatin treatment group declined(P
Keywords:Rosuvastatin  Aged  Unstable angina  Blood lipid  C-reaction protein
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号